Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_ffipsc197_promoter_n_PM_14_58_10			1	0.2	1.11E-04	MMP7	antibacterial peptide secretion [BP]
CG_ffipsc197_promoter_n_PM_12_56_7			1	0.2	2.29E-04	PON3	dihydrocoumarin hydrolase activity [MF], phenylacetate catabolic process [BP], 3,4-dihydrocoumarin hydrolase activity [MF]
CG_ffipsc197_promoter_n_PM_12_230_6			4	0.8	1.43E-04	SORBS2, TUBA1B	structural constituent of cytoskeleton [MF]
CG_ffipsc197_promoter_n_PM_12_62_6			2	0.4	2.39E-05	MYL2, MAX	muscle cell fate specification [BP], response to insulin stimulus [BP], cellular response to peptide hormone stimulus [BP]
CG_ffipsc197_promoter_n_PM_12_320_6			2	0.4	2.05E-05	DNPH1	deoxyribonucleoside monophosphate catabolic process [BP], nucleoside deoxyribosyltransferase activity [MF], deoxyribonucleoside 5'-monophosphate N-glycosidase activity [MF]
CG_ffipsc197_promoter_n_PM_12_31_5			2	0.4	2.54E-05	RPS6KA5, SLC25A17	ADP transmembrane transporter activity [MF], FMN transmembrane transporter activity [MF], NAD transport [BP], FAD transmembrane transporter activity [MF], NAD transporter activity [MF], histone H2A-S1 phosphorylation [BP], ATP transmembrane transporter activity [MF], coenzyme A transmembrane transporter activity [MF], histone H3-S28 phosphorylation [BP], histone H3-S10 phosphorylation [BP], AMP transmembrane transporter activity [MF], coenzyme A transmembrane transport [BP], AMP transport [BP], ADP transport [BP], FAD transmembrane transport [BP]
CG_ffipsc197_promoter_n_PM_12_43_7			2	0.4	1.04E-04	PCSK6	nerve growth factor production [BP]
CG_ffipsc197_promoter_n_PM_12_60_17			3	0.6	3.50E-05	CHCHD4	protein import into mitochondrial intermembrane space [BP]
CG_ffipsc197_promoter_n_PM_16_43_9			1	0.2	6.06E-05	APOA2, TOP2A, SLC16A1	mevalonate transport [BP], positive regulation of retroviral genome replication [BP], negative regulation of cholesterol transporter activity [BP], DNA topoisomerase complex (ATP-hydrolyzing) [CC], viral integration complex [CC], mevalonate transmembrane transporter activity [MF]
CG_ffipsc197_promoter_n_PM_14_47_16			5	0.8	6.46E-05	PLAT	positive regulation of ovulation [BP]
CG_ffipsc197_promoter_n_PM_12_319_10			3	0.6	2.85E-04	MAP3K11, SUMF1, SLC27A5, S100A11	identical protein binding [MF], cholate-CoA ligase activity [MF], JUN kinase kinase kinase activity [MF], protein homodimerization activity [MF]
CG_ffipsc197_promoter_n_PM_12_299_6			2	0.4	1.55E-04	HORMAD1, GOLPH3, ATP2A3, IL4I1	regulation of homologous chromosome segregation [BP], nuclear membrane [CC], L-amino-acid oxidase activity [MF], meiotic recombination checkpoint [BP]
CG_ffipsc197_promoter_n_PM_12_34_15			2	0.4	1.53E-04	CYP24A1	25-hydroxycholecalciferol-24-hydroxylase activity [MF], 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity [MF]
CG_ffipsc197_promoter_n_PM_12_183_6			2	0.4	2.03E-04	DSCAML1, CYBA	smooth muscle hypertrophy [BP], dendrite self-avoidance [BP], negative regulation of glomerular filtration by angiotensin [BP]
CG_ffipsc197_promoter_n_PM_12_54_8			1	0.2	5.30E-05	ENG	chronological cell aging [BP], detection of hypoxia [BP]
CG_ffipsc197_promoter_n_PM_12_112_8			2	0.4	1.70E-04	LAMTOR1	endosome localization [BP]
CG_ffipsc197_promoter_n_PM_12_29_7			2	0.4	1.13E-04	DUSP16, GFAP, PPP3CB	MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], MAPK export from nucleus [BP], dephosphorylation [BP], positive regulation of Schwann cell proliferation [BP]
CG_ffipsc197_promoter_n_PM_18_19_17			4	0.8	3.61E-05	PPAP2A, SNX8	early endosome to Golgi transport [BP], intracellular steroid hormone receptor signaling pathway [BP], androgen receptor signaling pathway [BP]
CG_ffipsc197_promoter_n_PM_12_33_7			1	0.2	3.45E-05	GALNS	N-acetylgalactosamine-6-sulfatase activity [MF]
CG_ffipsc197_promoter_n_PM_12_309_5			2	0.4	2.48E-04	NLRP12, SHQ1	release of cytoplasmic sequestered NF-kappaB [BP], negative regulation of interleukin-1 secretion [BP], negative regulation of rRNA processing [BP], regulation of interleukin-18 biosynthetic process [BP], negative regulation of Toll signaling pathway [BP]
CG_ffipsc197_promoter_n_PM_16_22_12			5	1.0	4.03E-05	PTPRN2	negative regulation of GTPase activity [BP]
CG_ffipsc197_promoter_n_PM_18_12_16			3	0.6	3.09E-05	NCOR1	regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP], regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc197_promoter_n_PM_14_50_8			4	0.6	1.16E-05	CRAT	carnitine O-acetyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_12_88_4			2	0.4	9.20E-05	DCTD, PKP2, PLOD3	dCMP deaminase activity [MF], procollagen glucosyltransferase activity [MF], adherens junction maintenance [BP]
CG_ffipsc197_promoter_n_PM_18_21_21			2	0.4	4.42E-05	NCOA6, TIA1, TRIP12	negative regulation of cytokine biosynthetic process [BP], thyroid hormone receptor binding [MF]
CG_ffipsc197_promoter_n_PM_12_263_12			3	0.6	1.90E-04	SLC35D1	UDP-glucuronic acid transmembrane transporter activity [MF], UDP-N-acetylgalactosamine transport [BP], UDP-glucuronic acid transport [BP], UDP-N-acetylgalactosamine transmembrane transporter activity [MF]
CG_ffipsc197_promoter_n_PM_12_256_5			2	0.4	2.55E-04	MAN2B1	protein deglycosylation [BP]
CG_ffipsc197_promoter_n_PM_12_167_4			2	0.4	1.45E-04	SDF4	zymogen granule exocytosis [BP]
CG_ffipsc197_promoter_n_PM_12_280_11			5	0.8	1.08E-04	SORBS1	insulin receptor complex [CC]
CG_ffipsc197_promoter_n_PM_12_100_8			2	0.4	6.85E-05	KCNH2, PDIA6, KCNA2, SHH, CALR3, ERO1L	endoplasmic reticulum lumen [CC], delayed rectifier potassium channel activity [MF], electron transport chain [BP], mesenchymal smoothened signaling pathway involved in prostate gland development [BP], regulation of mesenchymal cell proliferation involved in prostate gland development [BP], positive regulation of skeletal muscle cell proliferation [BP], negative regulation of kidney smooth muscle cell differentiation [BP], multicellular structure septum development [BP], negative regulation of ureter smooth muscle cell differentiation [BP], positive regulation of ureter smooth muscle cell differentiation [BP], positive regulation of sclerotome development [BP], positive regulation of kidney smooth muscle cell differentiation [BP]
CG_ffipsc197_promoter_n_PM_16_7_8			3	0.6	5.29E-05	HLCS, PC	biotin binding [MF], biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [MF], biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [MF], protein biotinylation [BP], biotin-[acetyl-CoA-carboxylase] ligase activity [MF], biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [MF], biotin-protein ligase activity [MF], histone biotinylation [BP], pyruvate carboxylase activity [MF]
CG_ffipsc197_promoter_n_PM_12_161_12			3	0.6	4.95E-05	DHFRL1, NCOR2	dihydrofolate reductase activity [MF], thymidine biosynthetic process [BP], regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc197_promoter_n_PM_12_153_9			2	0.4	2.56E-05	STMN3	negative regulation of Rac protein signal transduction [BP]
CG_ffipsc197_promoter_n_PM_12_258_8			3	0.6	8.98E-05	SLC35D2, POLG2, SLC43A2, SLCO2A1, SLC4A11	phosphoenolpyruvate-dependent sugar phosphotransferase system [BP], mitochondrial chromosome [CC], borate transmembrane transporter activity [MF], borate transport [BP], prostaglandin transmembrane transporter activity [MF], transmembrane transport [BP], borate transmembrane transport [BP]
CG_ffipsc197_promoter_n_PM_14_3_7			3	0.6	1.43E-04	SLC30A3, GSK3B, S100A7	positive regulation of granulocyte chemotaxis [BP], negative regulation of type B pancreatic cell development [BP], zinc transporting ATPase activity [MF], sequestering of metal ion [BP], canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process [BP], superior temporal gyrus development [BP]
CG_ffipsc197_promoter_n_PM_18_35_45			5	0.8	9.41E-05	BAG6	negative regulation of proteasomal ubiquitin-dependent protein catabolic process [BP]
CG_ffipsc197_promoter_n_PM_16_38_36			4	0.8	1.00E-04	EPOR	erythropoietin receptor activity [MF]
CG_ffipsc197_promoter_n_PM_12_165_5			1	0.2	2.61E-04	F3	activation of blood coagulation via clotting cascade [BP], activation of plasma proteins involved in acute inflammatory response [BP], positive regulation of platelet-derived growth factor receptor signaling pathway [BP]
CG_ffipsc197_promoter_n_PM_12_294_9			4	0.8	2.60E-04	SLC30A2	positive regulation of sequestering of zinc ion [BP]
CG_ffipsc197_promoter_n_PM_12_91_6			2	0.4	1.51E-04	NR0B1, TDP2, RELN, COQ3, CRAT	3-demethylubiquinone-9 3-O-methyltransferase activity [MF], DNA hairpin binding [MF], tyrosyl-RNA phosphodiesterase activity [MF], 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [MF], 5'-tyrosyl-DNA phosphodiesterase activity [MF], positive regulation of long-term synaptic potentiation [BP], carnitine O-acetyltransferase activity [MF], hexaprenyldihydroxybenzoate methyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_14_64_17			3	0.6	3.70E-05	ZER1, ATP5G2, CLIP1	macropinosome [CC], ATP hydrolysis coupled proton transport [BP]
CG_ffipsc197_promoter_n_PM_12_248_4			2	0.4	1.99E-05	SNAPC4	snRNA-activating protein complex [CC], snRNA transcription from RNA polymerase III promoter [BP], snRNA transcription from RNA polymerase II promoter [BP]
CG_ffipsc197_promoter_n_PM_12_84_9			2	0.4	2.18E-04	ACD, FOSL1	vitellogenesis [BP], DNA polymerase binding [MF], positive regulation of single-stranded telomeric DNA binding [BP]
CG_ffipsc197_promoter_n_PM_12_25_11			2	0.2	1.08E-04	CHEK2	signal transduction involved in intra-S DNA damage checkpoint [BP]
CG_ffipsc197_promoter_n_PM_12_254_7			3	0.6	1.02E-04	FA2H	sebaceous gland cell differentiation [BP], fatty acid alpha-hydroxylase activity [MF]
CG_ffipsc197_promoter_n_PM_14_71_17			7	1.0	4.79E-05	ATP9A, ATP8B3	phospholipid-translocating ATPase activity [MF], phospholipid translocation [BP]
CG_ffipsc197_promoter_n_PM_12_288_7			2	0.4	3.27E-05	IL2, NGEF, CIAPIN1	apoptotic process [BP], kappa-type opioid receptor binding [MF]
CG_ffipsc197_promoter_n_PM_18_34_85			4	0.8	5.78E-05	HAS1, SLC9A1	hyaluronan metabolic process [BP]
CG_ffipsc197_promoter_n_PM_12_189_4			2	0.4	1.32E-04	CTC1, LIF, PRIM1, REV1	deoxycytidyl transferase activity [MF], positive regulation of histone H3-K27 acetylation [BP], positive regulation of protein localization to nucleus [BP], telomere maintenance [BP], DNA replication [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF], error-prone translesion synthesis [BP]
CG_ffipsc197_promoter_n_PM_18_16_19			3	0.6	4.49E-05	EZH2, SETD2	histone-lysine N-methyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_12_199_9			2	0.4	1.64E-05	RBP4, SYTL4	retinol transporter activity [MF], positive regulation of protein secretion [BP], retinol transport [BP]
CG_ffipsc197_promoter_n_PM_12_52_8			3	0.6	7.45E-05	YPEL1, CATSPER2, RXRG	cilium [CC], regulation of myelination [BP]
CG_ffipsc197_promoter_n_PM_12_170_5			1	0.2	2.78E-05	RIC3, ALG12	protein binding involved in protein folding [MF], dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [MF], alpha-1,6-mannosyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_12_42_11			2	0.4	3.69E-05	PDGFB, DNASE2	negative regulation of phosphatidylinositol biosynthetic process [BP], superoxide-generating NADPH oxidase activator activity [MF], paracrine signaling [BP], metanephric glomerular endothelium development [BP], metanephric glomerular mesangial cell development [BP], deoxyribonuclease II activity [MF], cellular response to mycophenolic acid [BP], positive regulation of glomerular mesangial cell proliferation [BP]
CG_ffipsc197_promoter_n_PM_12_14_6			1	0.2	5.82E-05	HTR2A, UROS, LIF	phospholipase C-activating serotonin receptor signaling pathway [BP], negative regulation of hormone secretion [BP], cellular response to amine stimulus [BP], uroporphyrinogen-III synthase activity [MF], positive regulation of histone H3-K27 acetylation [BP], positive regulation of protein localization to nucleus [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF]
CG_ffipsc197_promoter_n_PM_12_127_7			6	1.0	6.20E-05	GBA	ceramide biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_16_10_20			4	0.8	6.82E-05	SNRPG, CPSF1, CYP51A1, DIMT1	termination of RNA polymerase II transcription [BP], 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [MF], cholesterol biosynthetic process via 24,25-dihydrolanosterol [BP], sterol 14-demethylase activity [MF]
CG_ffipsc197_promoter_n_PM_18_27_13			4	0.8	5.19E-05	CENPT, COG7, CHD4, GOLGA3	Golgi transport complex [CC], chromosome organization [BP], chromatin modification [BP]
CG_ffipsc197_promoter_n_PM_16_36_18			1	0.2	3.86E-05	MED1, EIF5A2, DUSP16, GLDC, GPCPD1, DNPH1	MAPK export from nucleus [BP], MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], glycine dehydrogenase (decarboxylating) activity [MF], small molecule metabolic process [BP], nucleoside deoxyribosyltransferase activity [MF], glycerophosphocholine phosphodiesterase activity [MF], deoxyribonucleoside 5'-monophosphate N-glycosidase activity [MF], polyamine homeostasis [BP]
CG_ffipsc197_promoter_n_PM_12_46_12			2	0.4	2.10E-05	EXT1, BUD13	RES complex [CC], heparan sulfate N-acetylglucosaminyltransferase activity [MF], N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [MF], glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [MF], heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_12_307_5			1	0.2	6.38E-05	EIF2AK2, MCEE	L-methylmalonyl-CoA metabolic process [BP], methylmalonyl-CoA epimerase activity [MF], evasion or tolerance by virus of host immune response [BP]
CG_ffipsc197_promoter_n_PM_12_186_8			1	0.2	3.86E-04	ABCB6	heme-transporting ATPase activity [MF], detoxification of cadmium ion [BP]
CG_ffipsc197_promoter_n_PM_14_27_12			1	0.2	6.98E-05	LACRT, CLK4, CAMK2D	calcium-mediated signaling [BP], protein autophosphorylation [BP], positive regulation of NFAT protein import into nucleus [BP], tear secretion [BP]
CG_ffipsc197_promoter_n_PM_12_24_7			2	0.4	5.79E-05	GHRH, SLC22A6	renal tubular secretion [BP], growth hormone-releasing hormone receptor binding [MF]
CG_ffipsc197_promoter_n_PM_12_311_13			2	0.4	1.93E-04	ERBB4, PGAM2	central nervous system morphogenesis [BP], 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [MF], cardiac muscle tissue regeneration [BP]
CG_ffipsc197_promoter_n_PM_12_174_6			2	0.4	3.75E-05	IRX2, SRPR	signal recognition particle binding [MF], proximal/distal pattern formation involved in metanephric nephron development [BP], signal recognition particle receptor complex [CC]
CG_ffipsc197_promoter_n_PM_16_13_11			5	1.0	7.10E-05	ASNS	L-asparagine biosynthetic process [BP], asparagine synthase (glutamine-hydrolyzing) activity [MF], asparagine biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_12_113_6			2	0.4	1.05E-04	WAPAL, PKD1L3, NAE1	NEDD8 activating enzyme activity [MF], detection of chemical stimulus involved in sensory perception of sour taste [BP], negative regulation of sister chromatid cohesion [BP], sour taste receptor activity [MF]
CG_ffipsc197_promoter_n_PM_12_145_8			2	0.4	1.04E-04	QRFP, NODAL	transforming growth factor beta receptor signaling pathway involved in primitive streak formation [BP], epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [BP], axial mesodermal cell fate specification [BP], orexigenic neuropeptide QRFP receptor binding [MF], inhibition of neuroepithelial cell differentiation [BP]
CG_ffipsc197_promoter_n_PM_16_3_17			4	0.8	5.43E-05	SMARCC1, DPF1, SUPT16H	nBAF complex [CC], nucleosome disassembly [BP]
CG_ffipsc197_promoter_n_PM_12_97_13			4	0.8	6.68E-05	SLX4, GBGT1	ERCC4-ERCC1 complex [CC], globoside alpha-N-acetylgalactosaminyltransferase activity [MF], Holliday junction resolvase complex [CC]
CG_ffipsc197_promoter_n_PM_12_111_6			4	0.8	1.07E-04	C3AR1	C3a anaphylatoxin receptor activity [MF], complement component C3a receptor activity [MF]
CG_ffipsc197_promoter_n_PM_12_147_5			2	0.4	3.31E-05	PSPN	axon guidance [BP]
CG_ffipsc197_promoter_n_PM_12_252_7			4	0.8	2.54E-05	RNF43	Wnt receptor catabolic process [BP]
CG_ffipsc197_promoter_n_PM_12_159_6			2	0.4	4.49E-05	XBP1	serotonin secretion, neurotransmission [BP], epithelial cell maturation involved in salivary gland development [BP]
CG_ffipsc197_promoter_n_PM_12_173_12			5	0.8	2.19E-05	PRKCQ	positive regulation of T-helper 2 cell activation [BP]
CG_ffipsc197_promoter_n_PM_12_190_8			2	0.4	9.34E-05	DPM1	dolichol-phosphate-mannose synthase complex [CC], protein O-linked mannosylation [BP], protein mannosylation [BP], dolichyl-phosphate-mannose-protein mannosyltransferase activity [MF], dolichyl-phosphate beta-D-mannosyltransferase activity [MF], dolichol metabolic process [BP]
CG_ffipsc197_promoter_n_PM_12_45_12			2	0.4	1.23E-04	POLG2, AADAT, KLK14, QDPR	NADH binding [MF], 2-aminoadipate transaminase activity [MF], 6,7-dihydropteridine reductase activity [MF], seminal clot liquefaction [BP], mitochondrial chromosome [CC]
CG_ffipsc197_promoter_n_PM_12_82_6			3	0.6	1.23E-04	TAPBP	peptide antigen-transporting ATPase activity [MF], peptide antigen stabilization [BP]
CG_ffipsc197_promoter_n_PM_14_31_17			4	0.8	5.01E-05	NAGA	alpha-N-acetylgalactosaminidase activity [MF]
CG_ffipsc197_promoter_n_PM_12_64_9			2	0.4	2.53E-04	APBB1, ATP8B3, MYL2, ILVBL, DTYMK, WDHD1, HPGDS, SLC7A10	nucleoside monophosphate phosphorylation [BP], nucleoside phosphate kinase activity [MF], magnesium ion binding [MF], negative regulation of thymidylate synthase biosynthetic process [BP], heterochromatin maintenance [BP], muscle cell fate specification [BP], D-alanine transport [BP]
CG_ffipsc197_promoter_n_PM_12_216_13			2	0.4	5.23E-05	PTRF, LUZP1, PRLR	prolactin signaling pathway [BP], neural fold bending [BP], rRNA primary transcript binding [MF], prolactin receptor activity [MF]
CG_ffipsc197_promoter_n_PM_12_278_6			5	0.8	8.53E-05	PPA1, PHB	diphosphate metabolic process [BP], negative regulation of glucocorticoid receptor signaling pathway [BP]
CG_ffipsc197_promoter_n_PM_12_206_5			4	0.8	4.21E-05	LONP1, DLX2, LONRF1, SEC11A	proteolysis [BP], proteolysis involved in cellular protein catabolic process [BP], single-stranded RNA binding [MF], ATP-dependent peptidase activity [MF]
CG_ffipsc197_promoter_n_PM_12_196_5			3	0.6	8.76E-05	A4GNT	galactosyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_12_212_13			5	0.8	4.20E-05	ACTC1	actomyosin, actin part [CC]
CG_ffipsc197_promoter_n_PM_12_168_8			5	0.6	1.20E-04	STOML2, HSPD1	positive regulation of T cell mediated immune response to tumor cell [BP], cardiolipin binding [MF], positive regulation of mitochondrial DNA replication [BP], positive regulation of cardiolipin metabolic process [BP]
CG_ffipsc197_promoter_n_PM_12_277_3			2	0.4	1.11E-04	DAPK2	autophagic vacuole lumen [CC]
CG_ffipsc197_promoter_n_PM_12_222_6			2	0.4	2.16E-04	HDAC3, PSRC1	spindle microtubule [CC]
CG_ffipsc197_promoter_n_PM_14_23_4			1	0.2	4.90E-05	FGF19	negative regulation of bile acid biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_12_180_8			3	0.6	1.66E-04	BCDIN3D, BAZ1B, NACA, IL10	negative regulation of chronic inflammatory response to antigenic stimulus [BP], negative regulation of myeloid dendritic cell activation [BP], interleukin-10 receptor binding [MF], vitamin D receptor activator activity [MF], negative regulation of interferon-alpha biosynthetic process [BP], nascent polypeptide-associated complex [CC], negative regulation of transcription from RNA polymerase II promoter involved in heart development [BP], negative regulation of pre-miRNA processing [BP], DNA replication-dependent nucleosome disassembly [BP]
CG_ffipsc197_promoter_n_PM_12_152_10			2	0.4	2.55E-05	GNAT3, RP1L1, CCKAR, SLC6A3	photoreceptor outer segment [CC], response to nicotine [BP], dopamine transmembrane transporter activity [MF], cholecystokinin receptor activity [MF], dopamine:sodium symporter activity [MF]
CG_ffipsc197_promoter_n_PM_12_175_10			2	0.4	4.69E-05	PGAM2	2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [MF]
CG_ffipsc197_promoter_n_PM_12_235_17			4	0.8	1.12E-04	CRP	choline binding [MF]
CG_ffipsc197_promoter_n_PM_12_26_9			1	0.2	3.72E-05	STAT5B, ABCB9, IL12RB1	positive regulation of activated T cell proliferation [BP], positive regulation of T cell mediated cytotoxicity [BP]
CG_ffipsc197_promoter_n_PM_14_2_11			3	0.6	2.08E-04	AGMAT	agmatine biosynthetic process [BP], agmatinase activity [MF], putrescine biosynthetic process from arginine [BP]
CG_ffipsc197_promoter_n_PM_12_17_13			3	0.6	2.25E-04	GHSR, LPCAT1, PODXL	growth hormone secretagogue receptor activity [MF], regulation of microvillus assembly [BP], negative regulation of phosphatidylcholine biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_12_185_3			1	0.2	2.63E-04	ROCK2	positive regulation of centrosome duplication [BP]
CG_ffipsc197_promoter_n_PM_12_243_8			2	0.4	5.29E-05	MCCC1, P2RX1	external side of cell outer membrane [CC], biotin metabolic process [BP], methylcrotonoyl-CoA carboxylase activity [MF]
CG_ffipsc197_promoter_n_PM_12_154_9			2	0.4	5.03E-05	PITPNM1, RHOC	cleavage furrow [CC]
CG_ffipsc197_promoter_n_PM_16_1_83			6	1.0	7.13E-05	TOPBP1, PLAUR, PIGS, EYA1, DPM3, DCLRE1C, RFWD3	C-terminal protein lipidation [BP], response to ionizing radiation [BP]
CG_ffipsc197_promoter_n_PM_12_269_10			2	0.4	2.31E-04	KDELR2	KDEL sequence binding [MF]
CG_ffipsc197_promoter_n_PM_12_255_11			1	0.2	1.00E-04	HTR1B, CNR2	response to mineralocorticoid stimulus [BP], negative regulation of synaptic transmission, GABAergic [BP]
CG_ffipsc197_promoter_n_PM_12_12_5			3	0.6	9.89E-05	OSM	oncostatin-M receptor binding [MF]
CG_ffipsc197_promoter_n_PM_12_104_8			2	0.4	1.66E-04	RLBP1, FIBCD1, CABP5, CELSR1, NCKAP1, RPS6KA3	apical protein localization [BP], response to stimulus [BP], signal transduction [BP]
CG_ffipsc197_promoter_n_PM_12_49_8			1	0.2	5.47E-05	RNF168	histone H2A-K15 ubiquitination [BP], histone H2A-K13 ubiquitination [BP]
CG_ffipsc197_promoter_n_PM_12_119_9			3	0.6	6.60E-05	PKP2, BLOC1S5	endosome to melanosome transport [BP], desmosome assembly [BP], adherens junction maintenance [BP]
CG_ffipsc197_promoter_n_PM_12_90_5			1	0.2	9.51E-05	CITED2, IL18	positive regulation of male germ cell proliferation [BP], interleukin-13 biosynthetic process [BP], positive regulation of blood vessel remodeling [BP], adrenal cortex formation [BP]
CG_ffipsc197_promoter_n_PM_16_14_7			4	0.8	3.96E-05	PLAUR	U-plasminogen activator receptor activity [MF]
CG_ffipsc197_promoter_n_PM_12_303_6			1	0.2	5.79E-05	VIPR2	vasoactive intestinal polypeptide receptor activity [MF]
CG_ffipsc197_promoter_n_PM_18_5_19			1	0.2	3.69E-05	LUZP1, POLG2	neural fold bending [BP], mitochondrial chromosome [CC]
CG_ffipsc197_promoter_n_PM_16_12_36			4	0.8	4.65E-05	HDDC3, RNF43	Wnt receptor catabolic process [BP], guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF]
CG_ffipsc197_promoter_n_PM_12_226_5			3	0.6	9.68E-05	HSPA8, HSPG2, HMGCS1	extracellular vesicular exosome [CC], organic acid binding [MF], response to tellurium ion [BP], response to low light intensity stimulus [BP]
CG_ffipsc197_promoter_n_PM_12_72_5			1	0.2	2.46E-04	FUT3	cell-cell recognition [BP]
CG_ffipsc197_promoter_n_PM_16_25_15			3	0.6	3.26E-05	SIRT2, EIF4E	eukaryotic initiation factor 4G binding [MF], chromatin silencing at telomere [BP], tubulin deacetylase activity [MF]
CG_ffipsc197_promoter_n_PM_12_59_9			3	0.6	3.83E-05	ELAVL1, YBX2, IMPAD1	mRNA stabilization [BP], 3'-nucleotidase activity [MF], translational attenuation [BP]
CG_ffipsc197_promoter_n_PM_12_268_8			1	0.2	1.64E-05	SGSH, PRKD2	N-sulfoglucosamine sulfohydrolase activity [MF], positive regulation of histone deacetylase activity [BP]
CG_ffipsc197_promoter_n_PM_12_305_5			3	0.4	3.14E-04	DUOX2	adenohypophysis morphogenesis [BP]
CG_ffipsc197_promoter_n_PM_12_53_11			4	0.8	4.40E-05	TAS2R14	bitter taste receptor activity [MF]
CG_ffipsc197_promoter_n_PM_12_247_4			2	0.4	3.61E-05	NTRK3	modulation by virus of host transcription [BP], positive regulation of axon extension involved in regeneration [BP]
CG_ffipsc197_promoter_n_PM_18_32_12			2	0.4	5.38E-05	CAMKK2, MYO10, EEA1	vesicle fusion [BP], synaptic vesicle to endosome fusion [BP], serine-pyruvate aminotransferase complex [CC], calmodulin binding [MF]
CG_ffipsc197_promoter_n_PM_12_192_13			5	0.6	2.47E-05	GPR149	negative regulation of ovulation [BP], preantral ovarian follicle growth [BP]
CG_ffipsc197_promoter_n_PM_14_39_8			2	0.4	1.19E-05	CD63, SAR1B	regulation of rubidium ion transport [BP], cellular membrane organization [BP]
CG_ffipsc197_promoter_n_PM_14_51_5			1	0.2	4.42E-05	PEX11G, ACOX1	peroxisome fission [BP], peroxisomal membrane [CC]
CG_ffipsc197_promoter_n_PM_12_48_7			2	0.4	8.10E-05	MBOAT4	peptidyl-serine octanoylation [BP], serine O-acyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_12_166_11			3	0.6	1.08E-04	GP5, DAPK2, DOLK	autophagic vacuole lumen [CC], dolichyl diphosphate biosynthetic process [BP], collagen binding [MF], dolichol kinase activity [MF], dolichyl monophosphate biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_14_75_6			3	0.6	3.43E-05	NACA	negative regulation of transcription from RNA polymerase II promoter involved in heart development [BP], positive regulation of skeletal muscle tissue growth [BP], nascent polypeptide-associated complex [CC]
CG_ffipsc197_promoter_n_PM_14_25_16			4	0.8	2.59E-05	TUBGCP3, KCNB1, CACTIN	negative regulation of interferon-beta production [BP], negative regulation of type I interferon-mediated signaling pathway [BP], neuronal cell body membrane [CC], polar microtubule [CC]
CG_ffipsc197_promoter_n_PM_12_179_4			2	0.4	7.51E-05	SLC6A9	glycine:sodium symporter activity [MF]
CG_ffipsc197_promoter_n_PM_18_13_18			3	0.6	4.54E-05	GIGYF1	insulin-like growth factor receptor signaling pathway [BP]
CG_ffipsc197_promoter_n_PM_16_40_43			5	1.0	3.07E-05	TXNDC12, DDO	D-aspartate oxidase activity [MF], protein-disulfide reductase (glutathione) activity [MF]
CG_ffipsc197_promoter_n_PM_18_30_18			4	0.8	1.80E-05	USH1C, TERF2	telomeric loop formation [BP], parallel actin filament bundle assembly [BP], age-dependent telomere shortening [BP], negative regulation of telomere maintenance via semi-conservative replication [BP]
CG_ffipsc197_promoter_n_PM_12_245_8			2	0.4	7.32E-05	ACOX3	peroxisome [CC], pristanoyl-CoA oxidase activity [MF]
CG_ffipsc197_promoter_n_PM_12_20_11			3	0.6	1.69E-04	PCGF2, WNT9A, DSCAM	embryonic skeletal system morphogenesis [BP], positive regulation of axon extension involved in axon guidance [BP]
CG_ffipsc197_promoter_n_PM_12_318_11			1	0.2	2.62E-05	MST1R, GNRHR	gonadotropin-releasing hormone receptor activity [MF], macrophage colony-stimulating factor signaling pathway [BP], macrophage colony-stimulating factor receptor activity [MF]
CG_ffipsc197_promoter_n_PM_18_8_34			4	0.8	9.92E-05	LDB1, FOXO1, TOP2A, TLE1	chromatin binding [MF]
CG_ffipsc197_promoter_n_PM_12_276_7			2	0.4	1.85E-05	CEBPA, RS1, GCNT4	adaptation of rhodopsin mediated signaling [BP], inter-male aggressive behavior [BP], response to vitamin B2 [BP]
CG_ffipsc197_promoter_n_PM_12_142_8			2	0.4	7.75E-05	MSTN	negative regulation of skeletal muscle tissue growth [BP]
CG_ffipsc197_promoter_n_PM_18_23_29			4	0.8	6.15E-05	UNC13D	regulation of mast cell degranulation [BP]
CG_ffipsc197_promoter_n_PM_12_236_8			2	0.4	6.59E-05	CLPX, LCP1, PITPNA, ANGPT2	mitochondrial endopeptidase Clp complex [CC], organ regeneration [BP], stearic acid binding [MF]
CG_ffipsc197_promoter_n_PM_12_158_8			5	0.8	6.98E-05	EXT1, SGPP1, SLC30A1	negative regulation of zinc ion transmembrane import [BP], detoxification of cadmium ion [BP], N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [MF], heparan sulfate N-acetylglucosaminyltransferase activity [MF], sphinganine-1-phosphate metabolic process [BP], sphingosine-1-phosphate phosphatase activity [MF]
CG_ffipsc197_promoter_n_PM_12_260_7			1	0.2	2.79E-05	DNAJC2	'de novo' cotranslational protein folding [BP]
CG_ffipsc197_promoter_n_PM_12_274_7			1	0.2	2.21E-05	DCAKD	dephospho-CoA kinase activity [MF]
CG_ffipsc197_promoter_n_PM_12_234_5			1	0.2	1.55E-04	CRYL1, FOXRED2, COL4A1, COL1A1, RHOA, BBC3, PES1	trabecula morphogenesis [BP], positive regulation of neuron apoptotic process [BP], response to amino acid stimulus [BP], endoplasmic reticulum lumen [CC], cellular response to amino acid stimulus [BP], platelet-derived growth factor binding [MF], protein localization to organelle [BP], L-gulonate 3-dehydrogenase activity [MF]
CG_ffipsc197_promoter_n_PM_12_7_9			2	0.4	3.86E-05	SARDH	sarcosine dehydrogenase activity [MF]
CG_ffipsc197_promoter_n_PM_12_232_11			1	0.2	3.18E-04	B4GALT3, TNFRSF4	N-acetyllactosamine synthase activity [MF], positive regulation of immunoglobulin secretion [BP], beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_12_18_9			3	0.6	1.10E-04	SDHB	3 iron, 4 sulfur cluster binding [MF], succinate dehydrogenase (ubiquinone) activity [MF]
CG_ffipsc197_promoter_n_PM_12_176_7			2	0.4	2.30E-05	SEPT6, GRIK5, DOLK	dolichyl diphosphate biosynthetic process [BP], regulation of synaptic vesicle fusion to presynaptic membrane [BP], axon terminus [CC], dolichol kinase activity [MF], dolichyl monophosphate biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_12_281_11			3	0.6	9.83E-05	SLC19A1	methotrexate transport [BP], methotrexate transporter activity [MF]
CG_ffipsc197_promoter_n_PM_12_314_12			3	0.6	2.08E-04	DDIT3	regulation of transcription involved in anterior/posterior axis specification [BP], negative regulation of determination of dorsal identity [BP]
CG_ffipsc197_promoter_n_PM_14_68_12			3	0.6	1.31E-04	MDC1, TKT	glyceraldehyde-3-phosphate biosynthetic process [BP], transketolase activity [MF], FHA domain binding [MF], xylulose biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_14_57_4			1	0.2	8.62E-05	UCN, SREBF1, ELOVL6	negative regulation of hormone secretion [BP], response to food [BP], triglyceride biosynthetic process [BP], gastric emptying [BP]
CG_ffipsc197_promoter_n_PM_12_239_7			2	0.4	1.82E-04	OMG	regulation of collateral sprouting of intact axon in response to injury [BP]
CG_ffipsc197_promoter_n_PM_14_20_18			2	0.4	3.96E-05	HLA-B, MGEA5, TAPBP	positive regulation of protein complex disassembly [BP], integral to lumenal side of endoplasmic reticulum membrane [CC]
CG_ffipsc197_promoter_n_PM_12_272_9			2	0.4	1.86E-04	RS1	adaptation of rhodopsin mediated signaling [BP]
CG_ffipsc197_promoter_n_PM_16_44_18			5	1.0	2.83E-05	NKX2-6, GLI3	tongue development [BP]
CG_ffipsc197_promoter_n_PM_12_65_9			2	0.4	2.20E-04	SLC25A29	acyl carnitine transmembrane transporter activity [MF]
CG_ffipsc197_promoter_n_PM_14_66_7			1	0.2	1.98E-05	MTIF3	ribosome disassembly [BP]
CG_ffipsc197_promoter_n_PM_12_298_10			2	0.4	3.41E-04	KRT84, UBD	nail development [BP], negative regulation of mitotic prometaphase [BP]
CG_ffipsc197_promoter_n_PM_12_122_12			4	0.6	5.73E-05	UBQLN4	nuclear proteasome complex [CC], cytosolic proteasome complex [CC]
CG_ffipsc197_promoter_n_PM_16_6_17			1	0.2	1.54E-05	UBE2S, HIBADH	3-hydroxyisobutyrate dehydrogenase activity [MF], free ubiquitin chain polymerization [BP]
CG_ffipsc197_promoter_n_PM_12_78_14			2	0.4	1.53E-04	AXIN1, NTHL1	canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], axial mesoderm formation [BP], Wnt receptor signaling pathway involved in forebrain neuron fate commitment [BP], nucleotide-excision repair, DNA incision, 5'-to lesion [BP], olfactory placode formation [BP], optic placode formation [BP]
CG_ffipsc197_promoter_n_PM_12_11_10			2	0.4	3.67E-04	CRHR2	corticotrophin-releasing factor receptor activity [MF]
CG_ffipsc197_promoter_n_PM_14_37_14			2	0.4	5.29E-05	RUNX1, CHST10, PPA2, PTCD1, CBR4	positive regulation of progesterone secretion [BP], mitochondrial matrix [CC], HNK-1 sulfotransferase activity [MF]
CG_ffipsc197_promoter_n_PM_14_5_20			3	0.6	5.35E-05	TOP2A, TUBA1B	microtubule-based movement [BP], cytoskeleton-dependent intracellular transport [BP], viral integration complex [CC], DNA topoisomerase complex (ATP-hydrolyzing) [CC], microtubule-based process [BP]
CG_ffipsc197_promoter_n_PM_12_279_10			3	0.6	5.71E-05	SIRT2	chromatin silencing at telomere [BP]
CG_ffipsc197_promoter_n_PM_12_253_10			3	0.6	8.70E-06	AHI1	pronephric nephron tubule morphogenesis [BP], pronephric duct morphogenesis [BP], positive regulation of polarized epithelial cell differentiation [BP], Kupffer's vesicle development [BP]
CG_ffipsc197_promoter_n_PM_12_270_6			4	0.8	1.06E-04	YARS	interleukin-8 receptor binding [MF], tyrosyl-tRNA aminoacylation [BP], tyrosine-tRNA ligase activity [MF]
CG_ffipsc197_promoter_n_PM_12_155_4			2	0.4	1.18E-04	KCNJ1	regulation of G-protein activated inward rectifier potassium channel activity [BP]
CG_ffipsc197_promoter_n_PM_14_67_5			1	0.2	5.23E-05	TRPM7	calcium-dependent cell-matrix adhesion [BP]
CG_ffipsc197_promoter_n_PM_12_264_9			2	0.4	2.28E-04	KRT36, KRT38, KRT33B	intermediate filament [CC]
CG_ffipsc197_promoter_n_PM_18_9_45			4	0.8	3.08E-05	SKA2, PLEKHA7, CBX7, KIFC3, CREBBP, PCGF2	condensed chromosome outer kinetochore [CC], epithelial cell-cell adhesion [BP], PRC1 complex [CC], zonula adherens maintenance [BP], zonula adherens [CC]
CG_ffipsc197_promoter_n_PM_12_312_10			2	0.4	1.38E-04	MAD1L1	mitotic telophase [BP]
CG_ffipsc197_promoter_n_PM_18_4_26			4	0.8	7.52E-05	SLC35D1, TOPORS, SLC35B1	UDP-glucuronic acid transmembrane transporter activity [MF], UDP-N-acetylgalactosamine transmembrane transporter activity [MF], UDP-glucuronic acid transport [BP], DNA topoisomerase binding [MF], UDP-N-acetylgalactosamine transport [BP], UDP-galactose transmembrane transport [BP]
CG_ffipsc197_promoter_n_PM_14_42_13			3	0.6	1.84E-05	TUBB4A, IL2RA	interleukin-2 binding [MF], regulation of T cell homeostatic proliferation [BP], interleukin-2 receptor activity [MF], internode region of axon [CC]
CG_ffipsc197_promoter_n_PM_12_61_5			2	0.4	1.00E-04	PTK2	netrin-activated signaling pathway [BP]
CG_ffipsc197_promoter_n_PM_12_262_12			2	0.4	4.41E-04	SRXN1	sulfiredoxin activity [MF]
CG_ffipsc197_promoter_n_PM_12_208_9			2	0.4	1.82E-04	TOPORS, ACSS1, NR5A1, APTX, GAS6, DHX58	double-stranded RNA binding [MF], propionate biosynthetic process [BP], cellular response to vitamin K [BP], maintenance of protein location in nucleus [BP], DNA 5'-adenosine monophosphate hydrolase activity [MF], DNA topoisomerase binding [MF], negative regulation of renal albumin absorption [BP], acetate biosynthetic process [BP], negative regulation of oligodendrocyte apoptotic process [BP]
CG_ffipsc197_promoter_n_PM_12_267_6			2	0.4	3.39E-04	GPX1	response to symbiotic bacterium [BP]
CG_ffipsc197_promoter_n_PM_12_178_10			1	0.2	1.10E-04	MFSD10	tetracycline transport [BP], tetracycline transporter activity [MF]
CG_ffipsc197_promoter_n_PM_12_93_10			4	0.8	2.02E-05	SNRPA1, DGCR14, TREH	alpha,alpha-trehalase activity [MF], catalytic step 2 spliceosome [CC], trehalose catabolic process [BP], trehalose metabolic process [BP]
CG_ffipsc197_promoter_n_PM_14_4_10			2	0.4	4.50E-05	GCH1	7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_14_29_15			4	0.6	4.08E-05	LBX1, SULT2A1, P2RX1	external side of cell outer membrane [CC], bile-salt sulfotransferase activity [MF], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP]
CG_ffipsc197_promoter_n_PM_12_240_7			2	0.4	3.69E-05	APRT	grooming behavior [BP]
CG_ffipsc197_promoter_n_PM_12_9_9			3	0.6	2.01E-05	NUMBL, SEPHS1	selenide, water dikinase activity [MF], neuroblast division in subventricular zone [BP]
CG_ffipsc197_promoter_n_PM_12_302_8			3	0.4	8.70E-05	DKK3, ROR2, RLIM	negative regulation of canonical Wnt receptor signaling pathway [BP], random inactivation of X chromosome [BP]
CG_ffipsc197_promoter_n_PM_14_1_9			2	0.4	3.44E-05	NPTX1, LPCAT1, GRIK5	1-acylglycerophosphocholine O-acyltransferase activity [MF], regulation of synaptic vesicle fusion to presynaptic membrane [BP], 1-alkylglycerophosphocholine O-acetyltransferase activity [MF], negative regulation of phosphatidylcholine biosynthetic process [BP], axonogenesis involved in innervation [BP]
CG_ffipsc197_promoter_n_PM_12_95_17			2	0.4	1.35E-04	AP3B2	COPI-coated vesicle [CC]
CG_ffipsc197_promoter_n_PM_12_218_4			3	0.6	1.98E-04	RBP4, PKD1	retinol transporter activity [MF], genitalia development [BP], retinol transport [BP], metanephric distal tubule morphogenesis [BP]
CG_ffipsc197_promoter_n_PM_14_26_5			1	0.2	8.93E-05	NUP62, SLU7, HMGCL	pre-mRNA 3'-splice site binding [MF], nucleocytoplasmic shuttling complex [CC], hydroxymethylglutaryl-CoA lyase activity [MF], second spliceosomal transesterification activity [MF]
CG_ffipsc197_promoter_n_PM_14_74_9			3	0.6	3.93E-05	NCOR1, CASP9, BRCA1	spindle microtubule [CC], positive regulation of histone H3-K9 acetylation [BP], intrinsic apoptotic signaling pathway in response to DNA damage [BP], positive regulation of histone H4-K16 acetylation [BP], regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP], positive regulation of histone H4-K20 methylation [BP]
CG_ffipsc197_promoter_n_PM_12_233_6			1	0.2	8.64E-05	EEA1	synaptic vesicle to endosome fusion [BP], serine-pyruvate aminotransferase complex [CC]
CG_ffipsc197_promoter_n_PM_12_151_4			2	0.4	6.32E-05	LZTS1, CLN3	negative regulation of macroautophagy [BP]
CG_ffipsc197_promoter_n_PM_12_30_6			2	0.4	1.18E-04	HDAC4, HDDC3, F3	guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF], activation of blood coagulation via clotting cascade [BP], response to denervation involved in regulation of muscle adaptation [BP], activation of plasma proteins involved in acute inflammatory response [BP], positive regulation of platelet-derived growth factor receptor signaling pathway [BP]
CG_ffipsc197_promoter_n_PM_18_2_16			4	0.8	4.85E-05	CLTB, RASSF9	clathrin coat of coated pit [CC], trans-Golgi network transport vesicle membrane [CC]
CG_ffipsc197_promoter_n_PM_16_47_13			3	0.6	1.30E-05	MGARP, PEX11G, SIRT6, SLC38A7	nuclear telomeric heterochromatin [CC], regulation of peroxisome size [BP], L-methionine transmembrane transporter activity [MF], L-asparagine transmembrane transporter activity [MF], L-leucine transmembrane transporter activity [MF], cellular response to gonadotropin-releasing hormone [BP]
CG_ffipsc197_promoter_n_PM_12_242_5			2	0.4	1.80E-04	RAB3D, FBLN5, SDC1	myoblast development [BP], elastic fiber [CC], peptidyl-cysteine methylation [BP]
CG_ffipsc197_promoter_n_PM_12_202_10			3	0.4	7.54E-05	ARHGDIA, NGF	positive regulation of axonogenesis [BP]
CG_ffipsc197_promoter_n_PM_12_149_18			3	0.6	4.21E-05	BHLHE23, CYBA	smooth muscle hypertrophy [BP], negative regulation of glomerular filtration by angiotensin [BP], negative regulation of retinal cell programmed cell death [BP]
CG_ffipsc197_promoter_n_PM_12_98_7			4	0.8	9.07E-05	CDO1	cysteine dioxygenase activity [MF]
CG_ffipsc197_promoter_n_PM_12_231_8			3	0.6	2.19E-04	STAR	cellular response to luteinizing hormone stimulus [BP]
CG_ffipsc197_promoter_n_PM_12_143_4			1	0.2	2.97E-04	DPH5	diphthine synthase activity [MF]
CG_ffipsc197_promoter_n_PM_12_157_4			3	0.6	2.34E-04	TMLHE, GCLC	glutamate-cysteine ligase activity [MF], trimethyllysine dioxygenase activity [MF], glutamate-cysteine ligase complex [CC]
CG_ffipsc197_promoter_n_PM_12_133_15			6	1.0	5.67E-05	ACOX3	pristanoyl-CoA oxidase activity [MF]
CG_ffipsc197_promoter_n_PM_16_37_14			4	0.8	7.22E-05	TRPV3, TKT	negative regulation of hair cycle [BP], glyceraldehyde-3-phosphate biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_12_229_11			2	0.4	9.00E-05	BMP5, CHCHD4, WNT4, GFPT1	negative regulation of steroid biosynthetic process [BP], protein import into mitochondrial intermembrane space [BP], negative regulation of testosterone biosynthetic process [BP], negative regulation of testicular blood vessel morphogenesis [BP], glucosamine biosynthetic process [BP], positive regulation of cortisol biosynthetic process [BP], negative regulation of male gonad development [BP]
CG_ffipsc197_promoter_n_PM_16_39_9			2	0.4	1.93E-05	CD34, MKI67	paracrine signaling [BP], glomerular endothelium fenestra [CC], metanephric glomerular mesangial cell differentiation [BP], negative regulation of cellular response to hypoxia [BP], positive regulation of granulocyte colony-stimulating factor production [BP], cellular response to heat [BP], negative regulation of cellular response to heat [BP], sulfate binding [MF], mesangial cell-matrix adhesion [BP], negative regulation of interleukin-2 secretion [BP], extracellular vesicular exosome assembly [BP], positive regulation of glial cell line-derived neurotrophic factor secretion [BP]
CG_ffipsc197_promoter_n_PM_14_24_5			1	0.2	1.26E-04	ITGA5, AMIGO3	heterophilic cell-cell adhesion [BP]
CG_ffipsc197_promoter_n_PM_14_41_9			4	0.8	4.80E-05	TKT, APOA1, TPT1, HSPD1	glyceraldehyde-3-phosphate biosynthetic process [BP], positive regulation of T cell mediated immune response to tumor cell [BP], negative regulation of cell adhesion molecule production [BP], negative regulation of ectoderm development [BP]
CG_ffipsc197_promoter_n_PM_12_237_6			2	0.4	9.51E-05	CDK6	cell dedifferentiation [BP]
CG_ffipsc197_promoter_n_PM_14_14_12			4	0.8	2.71E-05	CHEK2, DNASE2	DNA catabolic process [BP], signal transduction involved in intra-S DNA damage checkpoint [BP], deoxyribonuclease II activity [MF]
CG_ffipsc197_promoter_n_PM_12_205_9			2	0.4	9.84E-05	BCL2L10, TNFRSF10B	activation of cysteine-type endopeptidase activity involved in apoptotic process [BP]
CG_ffipsc197_promoter_n_PM_12_5_7			4	0.6	2.93E-04	PRODH2, ANGPT2	proline dehydrogenase activity [MF], negative regulation of positive chemotaxis [BP]
CG_ffipsc197_promoter_n_PM_12_102_15			4	0.8	1.03E-04	CYBA, SLC17A7	smooth muscle hypertrophy [BP], sodium:inorganic phosphate symporter activity [MF], negative regulation of glomerular filtration by angiotensin [BP], sequestering of neurotransmitter [BP]
CG_ffipsc197_promoter_n_PM_16_19_32			7	1.0	2.48E-05	UIMC1, APBB1	positive regulation of DNA repair [BP]
CG_ffipsc197_promoter_n_PM_12_246_11			2	0.4	1.36E-04	SMUG1	single-strand selective uracil DNA N-glycosylase activity [MF]
CG_ffipsc197_promoter_n_PM_12_181_10			4	0.8	8.04E-05	GSR, CYB561, CCL23	glutathione-disulfide reductase activity [MF], negative regulation of C-C chemokine binding [BP], transmembrane electron transfer carrier [MF]
CG_ffipsc197_promoter_n_PM_14_16_7			2	0.4	1.84E-05	BLVRB	riboflavin reductase (NADPH) activity [MF]
CG_ffipsc197_promoter_n_PM_16_26_26			4	0.8	2.38E-05	GNE, ADAM8	N-acylmannosamine kinase activity [MF], positive regulation of neutrophil extravasation [BP], positive regulation of fibronectin-dependent thymocyte migration [BP], dense core granule membrane [CC], alpha9-beta1 integrin-ADAM8 complex [CC], positive regulation of eosinophil migration [BP], UDP-N-acetylglucosamine 2-epimerase activity [MF]
CG_ffipsc197_promoter_n_PM_18_1_30			3	0.6	3.40E-05	TGFBR3, CCNC, MED24, SRSF12, BRCA1	positive regulation of histone H4-K16 acetylation [BP], positive regulation of histone H3-K9 acetylation [BP], mediator complex [CC], negative regulation of centriole replication [BP], response to luteinizing hormone stimulus [BP], androgen receptor signaling pathway [BP], transforming growth factor beta receptor activity, type III [MF], positive regulation of histone H4-K20 methylation [BP], intracellular steroid hormone receptor signaling pathway [BP], BRCA1-BARD1 complex [CC], nucleoplasm [CC]
CG_ffipsc197_promoter_n_PM_12_283_9			2	0.4	1.66E-04	ZKSCAN2, PSIP1, FOXP1, PBRM1, MPO	chromatin binding [MF]
CG_ffipsc197_promoter_n_PM_16_21_20			5	1.0	3.53E-05	ATXN2, DDX6	cytoplasmic mRNA processing body assembly [BP], cytoplasmic stress granule [CC]
CG_ffipsc197_promoter_n_PM_12_293_17			1	0.2	9.21E-05	PSG2, PSG9, PSG5	female pregnancy [BP]
CG_ffipsc197_promoter_n_PM_12_310_12			2	0.4	1.58E-04	LGR4, XPO1	canonical Wnt receptor signaling pathway involved in metanephric kidney development [BP], annulate lamellae [CC]
CG_ffipsc197_promoter_n_PM_12_315_14			2	0.4	1.67E-04	RAB17	immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [BP]
CG_ffipsc197_promoter_n_PM_12_1_9			1	0.2	1.27E-05	TERT	telomeric template RNA reverse transcriptase activity [MF], telomeric RNA binding [MF]
CG_ffipsc197_promoter_n_PM_12_89_9			3	0.6	1.93E-04	SUV420H1, AVPR1A	V1A vasopressin receptor binding [MF], histone H4-K20 trimethylation [BP], cellular response to water deprivation [BP]
CG_ffipsc197_promoter_n_PM_12_141_4			1	0.2	2.42E-04	TAF2	metallopeptidase activity [MF]
CG_ffipsc197_promoter_n_PM_12_132_9			2	0.4	8.50E-05	IFNLR1, EXOSC5, TMEM184A	interleukin-28 receptor complex [CC], defense response to virus [BP], germ-line sex determination [BP]
CG_ffipsc197_promoter_n_PM_12_182_11			2	0.4	5.07E-04	EHD4	nucleic acid binding [MF]
CG_ffipsc197_promoter_n_PM_16_46_14			1	0.2	5.70E-05	ADA, KLHL6	regulation of cell-cell adhesion mediated by integrin [BP], germinal center formation [BP]
CG_ffipsc197_promoter_n_PM_12_51_9			4	0.8	1.90E-04	AP3D1	synaptic vesicle membrane organization [BP], antigen processing and presentation, exogenous lipid antigen via MHC class Ib [BP]
CG_ffipsc197_promoter_n_PM_12_188_11			2	0.4	2.07E-05	DHRS7C	longitudinal sarcoplasmic reticulum [CC]
CG_ffipsc197_promoter_n_PM_14_18_12			2	0.4	3.50E-05	USP7, DNMT1	maintenance of DNA methylation [BP]
CG_ffipsc197_promoter_n_PM_12_67_10			3	0.6	6.84E-05	LRPAP1, POLRMT	asialoglycoprotein receptor activity [MF], lipase binding [MF], negative regulation of beta-amyloid clearance [BP], rough endoplasmic reticulum lumen [CC], transcription initiation from mitochondrial promoter [BP], very-low-density lipoprotein particle receptor binding [MF], negative regulation of very-low-density lipoprotein particle clearance [BP]
CG_ffipsc197_promoter_n_PM_12_191_13			3	0.6	6.99E-05	STK3	hippo signaling cascade [BP]
CG_ffipsc197_promoter_n_PM_12_291_7			1	0.2	9.62E-05	SARS2	serine-tRNA ligase activity [MF], seryl-tRNA aminoacylation [BP]
CG_ffipsc197_promoter_n_PM_12_184_11			1	0.2	1.03E-04	IMMP2L, TRPV3, MIPEP	negative regulation of hair cycle [BP], mitochondrial inner membrane peptidase complex [CC], protein processing involved in protein targeting to mitochondrion [BP]
CG_ffipsc197_promoter_n_PM_12_128_4			2	0.4	7.89E-05	SMPD4	sphingomyelin phosphodiesterase D activity [MF]
CG_ffipsc197_promoter_n_PM_12_215_7			1	0.2	1.75E-05	PGGT1B, CDK5RAP2	negative regulation of centriole replication [BP], CAAX-protein geranylgeranyltransferase complex [CC], CAAX-protein geranylgeranyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_12_238_7			2	0.4	2.65E-05	NOX3, CHEK2, PDK4, AADAT, VWF	signal transduction involved in intra-S DNA damage checkpoint [BP], detection of gravity [BP], 2-aminoadipate transaminase activity [MF], Weibel-Palade body [CC], reactive oxygen species metabolic process [BP], protein homodimerization activity [MF]
CG_ffipsc197_promoter_n_PM_14_62_23			2	0.4	4.10E-05	BAZ2A, SSU72, CSTF3, NLRP10, SLC23A1	heterochromatin assembly involved in chromatin silencing [BP], helper T cell enhancement of adaptive immune response [BP], dehydroascorbic acid transport [BP], mRNA polyadenylation [BP]
CG_ffipsc197_promoter_n_PM_12_101_9			3	0.6	9.22E-05	NUMB, HAO1	long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity [MF], medium-chain-(S)-2-hydroxy-acid oxidase activity [MF], positive regulation of polarized epithelial cell differentiation [BP], (S)-2-hydroxy-acid oxidase activity [MF], neuroblast division in subventricular zone [BP], very-long-chain-(S)-2-hydroxy-acid oxidase activity [MF], glycolate catabolic process [BP], glycolate oxidase activity [MF], glyoxylate oxidase activity [MF]
CG_ffipsc197_promoter_n_PM_12_213_4			2	0.4	4.57E-05	ATP6V0A4	vacuolar proton-transporting V-type ATPase, V0 domain [CC]
CG_ffipsc197_promoter_n_PM_14_9_11			3	0.6	1.69E-05	PITPNA, BAD	cellular process regulating host cell cycle in response to virus [BP], positive regulation of type B pancreatic cell development [BP], positive regulation of glucokinase activity [BP], ADP metabolic process [BP], positive regulation of mitochondrial membrane potential [BP], stearic acid binding [MF], cellular response to chromate [BP], phosphatidylcholine transporter activity [MF], cellular response to nicotine [BP], response to oleic acid [BP], type B pancreatic cell proliferation [BP]
CG_ffipsc197_promoter_n_PM_12_261_8			3	0.6	1.77E-05	PCYT1A	choline-phosphate cytidylyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_12_219_10			2	0.4	3.52E-05	TRPV4	osmosensor activity [MF], cortical microtubule organization [BP], vasopressin secretion [BP], osmosensory signaling pathway [BP]
CG_ffipsc197_promoter_n_PM_16_31_11			1	0.2	3.18E-05	SDC3, ACSL1, CHSY1, ELOVL6, PRPF8, GPC4, DDX23	long-chain fatty-acyl-CoA biosynthetic process [BP], U5 snRNP [CC], chondroitin sulfate metabolic process [BP]
CG_ffipsc197_promoter_n_PM_12_308_4			2	0.4	3.26E-05	DPAGT1, PKD1L3, AQP7	UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [MF], dolichol biosynthetic process [BP], phospho-N-acetylmuramoyl-pentapeptide-transferase activity [MF], urea channel activity [MF], sour taste receptor activity [MF], detection of chemical stimulus involved in sensory perception of sour taste [BP]
CG_ffipsc197_promoter_n_PM_12_130_6			1	0.2	4.24E-05	MYBBP1A	NLS-dependent protein nuclear import complex [CC]
CG_ffipsc197_promoter_n_PM_12_244_8			2	0.4	9.54E-05	SIAE, DUSP16, HDDC3, CDKN1C	MAPK export from nucleus [BP], guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF], negative regulation of kinase activity [BP], MAPK phosphatase export from nucleus, leptomycin B sensitive [BP], negative regulation of phosphorylation [BP], sialate O-acetylesterase activity [MF]
CG_ffipsc197_promoter_n_PM_12_139_4			1	0.2	1.79E-05	IPPK, WARS, PTGIS, FADS3	inositol pentakisphosphate 2-kinase activity [MF], prostaglandin-I synthase activity [MF], tryptophanyl-tRNA aminoacylation [BP], inositol phosphorylation [BP], unsaturated fatty acid biosynthetic process [BP], tryptophan-tRNA ligase activity [MF]
CG_ffipsc197_promoter_n_PM_18_33_15			3	0.6	5.96E-05	KLK10	cell cycle [BP]
CG_ffipsc197_promoter_n_PM_12_121_14			3	0.6	4.13E-05	JAK3	negative regulation of FasL biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_12_217_7			2	0.4	3.67E-05	ACSM1	acyl-CoA ligase activity [MF], benzoate metabolic process [BP], butyrate metabolic process [BP]
CG_ffipsc197_promoter_n_PM_12_146_7			1	0.2	6.05E-05	CYP1B1, ZRANB3, CYP3A4	DNA rewinding [BP], oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [MF], oxygen binding [MF]
CG_ffipsc197_promoter_n_PM_12_209_8			2	0.4	6.97E-05	KIF18A, SLC17A7	sequestering of neurotransmitter [BP], sodium:inorganic phosphate symporter activity [MF], tubulin-dependent ATPase activity [MF]
CG_ffipsc197_promoter_n_PM_12_295_4			3	0.6	2.36E-05	MOGS, NDUFA12, SFTPB, SLC25A17	FMN transmembrane transporter activity [MF], mannosyl-oligosaccharide glucosidase activity [MF], FAD transmembrane transporter activity [MF], NAD transporter activity [MF], respiratory gaseous exchange [BP], FAD transmembrane transport [BP]
CG_ffipsc197_promoter_n_PM_12_304_6			2	0.4	2.61E-05	ADAP1	inositol 1,3,4,5 tetrakisphosphate binding [MF]
CG_ffipsc197_promoter_n_PM_12_220_5			1	0.2	8.46E-05	NLRP12, MOXD1	negative regulation of Toll signaling pathway [BP], regulation of interleukin-18 biosynthetic process [BP], dopamine beta-monooxygenase activity [MF]
CG_ffipsc197_promoter_n_PM_12_79_11			4	0.6	6.50E-05	SNAPC4, PLXNA4, DPYS	chemorepulsion of branchiomotor axon [BP], thymine binding [MF], snRNA transcription from RNA polymerase III promoter [BP], uracil binding [MF], snRNA-activating protein complex [CC], snRNA transcription from RNA polymerase II promoter [BP]
CG_ffipsc197_promoter_n_PM_12_92_6			2	0.4	2.18E-04	MYO1C, TNR, NOC2L	perineuronal net [CC], positive regulation of vascular endothelial growth factor signaling pathway [BP], stereocilium membrane [CC], negative regulation of axon extension involved in regeneration [BP], nucleolus to nucleoplasm transport [BP], myosin I complex [CC]
CG_ffipsc197_promoter_n_PM_12_96_5			3	0.6	7.92E-05	ABCA4	phospholipid transfer to membrane [BP]
CG_ffipsc197_promoter_n_PM_12_39_4			1	0.2	1.82E-04	TPH1	aromatic amino acid family metabolic process [BP]
CG_ffipsc197_promoter_n_PM_12_171_7			2	0.4	9.07E-05	SFRP1, ENPP2, SLU7, TRIM9	stromal-epithelial cell signaling involved in prostate gland development [BP], convergent extension involved in somitogenesis [BP], alkylglycerophosphoethanolamine phosphodiesterase activity [MF], positive regulation of fibroblast apoptotic process [BP], second spliceosomal transesterification activity [MF], negative regulation of SNARE complex assembly [BP], negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP]
CG_ffipsc197_promoter_n_PM_12_172_10			2	0.4	3.47E-05	PRHOXNB, IL22RA2	interleukin-22 binding [MF], interleukin-22 receptor activity [MF], urate catabolic process [BP], allantoin biosynthetic process [BP]
CG_ffipsc197_promoter_n_PM_14_30_9			2	0.4	2.97E-05	SNX5, MAD1L1	macropinocytic cup [CC], mitotic telophase [BP]
CG_ffipsc197_promoter_n_PM_12_317_11			2	0.4	8.35E-05	IDH1	isocitrate dehydrogenase (NADP+) activity [MF], glyoxylate cycle [BP]
CG_ffipsc197_promoter_n_PM_12_125_14			2	0.4	2.45E-05	EIF4E, NES, SOX18	eukaryotic initiation factor 4G binding [MF], positive regulation of intermediate filament depolymerization [BP], stem cell fate specification [BP], stem cell proliferation [BP]
CG_ffipsc197_promoter_n_PM_12_85_9			3	0.6	6.38E-05	ODC1	putrescine biosynthetic process from ornithine [BP], ornithine decarboxylase activity [MF]
CG_ffipsc197_promoter_n_PM_12_23_6			1	0.2	4.60E-05	ZER1, MARCH8, KLHL21, UBR4, TEX14	ubiquitin-protein ligase activity [MF], intercellular bridge organization [BP]
CG_ffipsc197_promoter_n_PM_14_34_11			4	0.8	5.74E-05	PDF, HAL, FASTK	histidine ammonia-lyase activity [MF], peptide deformylase activity [MF], Fas-activated serine/threonine kinase activity [MF]
CG_ffipsc197_promoter_n_PM_14_69_23			5	0.8	5.95E-05	SMARCC1, NRIP2, NRIP3, BAZ1B, OMA1, MUL1, BACE1	aspartic-type endopeptidase activity [MF], negative regulation of mitochondrial fusion [BP], WINAC complex [CC]
CG_ffipsc197_promoter_n_PM_12_32_15			2	0.4	6.34E-05	HTR2A, HORMAD1	phospholipase C-activating serotonin receptor signaling pathway [BP], meiotic recombination checkpoint [BP], regulation of homologous chromosome segregation [BP]
CG_ffipsc197_promoter_n_PM_12_13_7			2	0.2	1.38E-04	MAK, PLD6, ABHD11, MED26, DDX17	cardiolipin hydrolase activity [MF], hydrolase activity [MF], transcription coactivator activity [MF]
CG_ffipsc197_promoter_n_PM_12_71_11			4	0.8	7.95E-05	DLG4, ANKLE2	P2Y1 nucleotide receptor binding [MF], mitotic nuclear envelope reassembly [BP]
CG_ffipsc197_promoter_n_PM_12_131_10			2	0.4	1.90E-06	CCL19	interleukin-12 secretion [BP], positive regulation of dendritic cell dendrite assembly [BP], CCR10 chemokine receptor binding [MF], CCR7 chemokine receptor binding [MF], mature dendritic cell differentiation [BP], myeloid dendritic cell chemotaxis [BP]
CG_ffipsc197_promoter_n_PM_12_285_4			1	0.2	4.11E-05	GLYAT	glycine N-benzoyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_12_120_5			1	0.2	2.50E-05	ALDH9A1, SLC16A8	lactate transport [BP], 4-trimethylammoniobutyraldehyde dehydrogenase activity [MF], aminobutyraldehyde dehydrogenase activity [MF], lactate transmembrane transport [BP], lactate transmembrane transporter activity [MF], 1-pyrroline dehydrogenase activity [MF]
CG_ffipsc197_promoter_n_PM_12_169_14			3	0.6	1.43E-04	SALL1, HDAC5, GNPTAB	ureteric bud invasion [BP], carbohydrate phosphorylation [BP], olfactory bulb mitral cell layer development [BP], histone deacetylase complex [CC], histone deacetylation [BP], histone deacetylase activity [MF], inductive cell-cell signaling [BP], UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [MF]
CG_ffipsc197_promoter_n_PM_16_35_11			2	0.4	1.73E-04	ADAM17, FMN1, BST2, LSM4	negative regulation of egress of virus within host cell [BP], U6 snRNP [CC], response to high density lipoprotein particle stimulus [BP], negative regulation of plasmacytoid dendritic cell cytokine production [BP], positive regulation of actin nucleation [BP]
CG_ffipsc197_promoter_n_PM_12_66_6			3	0.6	2.79E-04	HMGB2, GAMT, SUN2	guanidinoacetate N-methyltransferase activity [MF], creatine biosynthetic process [BP], nuclear matrix anchoring at nuclear membrane [BP], nuclear migration along microfilament [BP], base-excision repair, DNA ligation [BP]
CG_ffipsc197_promoter_n_PM_12_144_12			2	0.4	2.13E-04	SLC6A9	glycine:sodium symporter activity [MF]
CG_ffipsc197_promoter_n_PM_18_6_23			4	0.8	5.84E-05	MEX3D, B9D2, SIN3A, WDR35	response to methylglyoxal [BP], microtubule basal body [CC], mRNA localization resulting in posttranscriptional regulation of gene expression [BP], negative regulation of histone H3-K27 acetylation [BP], cilium axoneme [CC]
CG_ffipsc197_promoter_n_PM_12_193_6			2	0.4	8.43E-05	SDS, PCBD1	response to cobalamin [BP], L-serine ammonia-lyase activity [MF], phenylalanine 4-monooxygenase activity [MF], L-threonine ammonia-lyase activity [MF], 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [MF]
CG_ffipsc197_promoter_n_PM_12_106_7			2	0.4	9.72E-05	NFS1	iron incorporation into metallo-sulfur cluster [BP], cysteine desulfurase activity [MF]
CG_ffipsc197_promoter_n_PM_12_204_7			2	0.4	1.94E-04	ARSA, AJUBA	negative regulation of hippo signaling cascade [BP], cerebroside-sulfatase activity [MF], regulation of cellular response to hypoxia [BP]
CG_ffipsc197_promoter_n_PM_18_15_22			1	0.2	5.92E-05	NAMPT, DTYMK	nucleoside phosphate kinase activity [MF], myoblast differentiation [BP], nicotinamide phosphoribosyltransferase activity [MF]
CG_ffipsc197_promoter_n_PM_12_110_9			2	0.4	2.94E-04	ZMYND8, HEYL, INTS1	AF-1 domain binding [MF], RNA polymerase II transcription corepressor activity [MF], U2 snRNA 3'-end processing [BP]
CG_ffipsc197_promoter_n_PM_12_80_10			2	0.4	7.25E-05	PAXIP1	positive regulation of histone H3-K36 methylation [BP]
CG_ffipsc197_promoter_n_PM_12_177_8			2	0.4	2.12E-04	UNC13D	granuloma formation [BP]
CG_ffipsc197_promoter_n_PM_12_282_4			3	0.6	1.05E-04	FIGNL1	hydrolase activity [MF]
CG_ffipsc197_promoter_n_PM_16_50_24			3	0.6	2.17E-05	RBP4	retinol transporter activity [MF], retinol transport [BP]
CG_ffipsc197_promoter_n_PM_12_37_9			2	0.4	2.56E-04	PIF1	ATP-dependent 5'-3' DNA/RNA helicase activity [MF]
CG_ffipsc197_promoter_n_PM_14_44_3			4	0.8	2.49E-05	C1QBP, EHMT2	positive regulation of mitochondrial translation [BP], mitochondrial ribosome binding [MF], negative regulation of MDA-5 signaling pathway [BP], positive regulation of trophoblast cell migration [BP], DNA methylation on cytosine within a CG sequence [BP], negative regulation of RIG-I signaling pathway [BP]
CG_ffipsc197_promoter_n_PM_14_43_11			4	0.8	2.37E-05	GAMT	guanidinoacetate N-methyltransferase activity [MF]